R2/3 gastrectomy for XXXX : an audited experience of a consecutive series.

@entity1 @entity706 @entity6595 @entity5 @entity189 @entity3 @entity356
A consecutive series of 27 @entity1 with @entity356 (24 @entity189 , 3 @entity706 ) have been staged at laparotomy using the Japanese criteria for macroscopic staging. In 20 @entity1 the radical R2/3 resection was considered potentially curative as defined by the Japanese Society for Research in @entity356 . The operative mortality in this subgroup was 1/20 (5 per cent) and 3/27 (11 per cent) in the entire series. Locoregional recurrence was not observed in the potentially curative group. Follow-up has varied from 6 months to 7 years. An overall survival of 12/27 (48 per cent) has been observed to date. Death from @entity5 dissemination is maximal in the first and second year after resection. The R2/3 resection was considered non-curative in seven @entity1 . In this subgroup there were two postoperative deaths and four have died of @entity3 within 12 months of the resection. The only 5 year survivor in this group had a @entity6595 .
